Published in Medical Letter on the CDC and FDA, October 20th, 1997
They told a U.S. Food and Drug Administration (FDA) advisory panel that checks around the world have turned up no evidence that anyone has contracted the brain-wasting CJD from blood transfusions, plasma, or other blood products.
"There is an infectious agent in blood that has never been shown to be transmitted in human beings," said William Freas, acting secretary of the FDA's transmissible encephalopathies advisory committee.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.